Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Gene therapies entities : Amgen inc. save search
Asia-Pacific Gene Therapy Markets, 2021-2030 - Product Launches and Grants / Outsourcing of Vector and Gene Therapy Manufacturing
Published: 2021-08-26 (Crawled : 18:00) - prnewswire.com
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: 0.25%
gene therapy therapy gene therapies grant
Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
Published: 2021-08-18 (Crawled : 17:00) - prnewswire.com
SYK | $336.03 -0.48% -0.37% 830K
|
Health Technology
|
| O: -0.04%
H: 0.04%
C: -1.45%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: -0.43%
H: 0.05%
C: -1.36%
MDT | News | $79.08 -0.22% 0.25% 4.6M
|
Health Technology
|
| O: 0.03%
H: 0.28%
C: -1.12%
ABBV | $164.25 1.05% 0.26% 3M
|
Health Technology
|
| O: -0.41%
H: 0.63%
C: -1.58%
MMM | $90.96 -0.1% 0.39% 2.9M
|
Producer Manufacturing
|
| O: -0.49%
H: 0.12%
C: -1.04%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: -0.29%
H: 0.35%
C: -1.6%
gene therapy therapy gene therapies
Sensorion Appoints Gene Therapy and Rare Disease Expert Nora Yang as Chief Scientific Officer
Published: 2021-06-10 (Crawled : 11:00) - biospace.com/
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: 0.02%
H: 2.4%
C: 2.12%
disease sensor gene therapy therapy gene therapies rare
APAC Gene Therapy Market Size To Be $6,931.5 Million by 2030 says P&S Intelligence
Published: 2021-06-02 (Crawled : 09:00) - prnewswire.com
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.37%
C: 0.02%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: 0.57%
H: 0.76%
C: 0.11%
gene therapy therapy gene therapies
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
Published: 2021-03-30 (Crawled : 22:00) - prnewswire.com
PFE A | $25.42 -1.05% 0.16% 40M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: -1.55%
H: 0.51%
C: -0.22%
BDX | $232.21 0.52% -0.04% 1.2M
|
Health Technology
|
| O: -0.01%
H: 0.25%
C: -0.82%
VCEL | $46.26 -2.65% -2.66% 320K
|
Health Technology
|
| O: 0.74%
H: 5.83%
C: 4.75%
QURE | $4.67 -0.64% -0.64% 830K
|
Health Technology
|
| O: -0.81%
H: 4.45%
C: 2.03%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.7%
H: 4.08%
C: 2.25%
BLUE | $0.9633 -2.73% -2.43% 8.4M
|
Health Technology
|
| O: 0.66%
H: 5.38%
C: 4.65%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: -0.21%
H: 0.29%
C: -0.17%
gene therapies gene therapy therapy drug device drug delivery liver
Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE A | $25.42 -1.05% 0.16% 40M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.31%
ORGO | $2.79 -2.45% -2.33% 800K
|
Finance
|
| O: 1.86%
H: 1.82%
C: -2.21%
AMGN | $264.07 -0.59% -0.59% 1.6M
|
Health Technology
|
| O: 0.15%
H: 1.81%
C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.